Almuradova D.M., Ravshanova N.B., Abdurakhimov A.I. Clinical Outcomes of EGFR-Targeted Therapy with Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis. ijmscr [Internet]. 2026 Mar. 31 [cited 2026 Apr. 11];6(03):82-6. Available from: https://theusajournals.com/index.php/ijmscr/article/view/9783